Inactive Instrument

All News Theseus Pharmaceuticals, Inc.

Equities

THRX

US88369M1018

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Theseus Pharmaceuticals, Inc. Announces Board Resignations	Feb. 14	CI
Theseus Pharmaceuticals Announces Closing of Tender Offer	Feb. 14	PR
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from NASDAQ Composite Index	Feb. 13	CI
Concentra Biosciences, LLC completed the acquisition of Theseus Pharmaceuticals, Inc..	Feb. 13	CI
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from S&P TMI Index	Feb. 08	CI
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals	Jan. 30	BU
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates DSKE, THRX, CONN	Jan. 11	PR
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX	Dec. 31	BU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN	Dec. 27	PR
Sector Update: Health Care Stocks Gain in Late Afternoon	Dec. 22	MT
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders	Dec. 22	BU
Sector Update: Health Care Stocks Higher Friday Afternoon	Dec. 22	MT
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right	Dec. 22	PR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX	Dec. 22	PR
Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra	Dec. 22	PR
Sector Update: Health Care Stocks Mixed Premarket Friday	Dec. 22	MT
Theseus Pharmaceuticals to be Acquired by Concentra Biosciences; Shares Rise Pre-Bell	Dec. 22	MT
Theseus Pharmaceuticals, Inc. Announces Employment Termination of Timothy P. Clackson as Chief Executive Officer, Effective December 7, 2023	Dec. 04	CI
Theseus Pharmaceuticals, Inc. Announces Management Changes	Dec. 04	CI
Theseus Pharmaceuticals Receives Acquisition Offers From Foresite, OrbiMed, Concentra Biosciences	Nov. 27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Theseus Pharmaceuticals, Inc.

Equities

THRX

US88369M1018

All News

Filters